Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 6, 1999, Pages 617-624

  Alvarez, Jean Claude ^a   Gluck, Nathalie ^b   Arnulf, Isabelle ^b   Quintin, Philippe ^b   Leboyer, Marion ^b   Pecquery, René ^b   Launay, Jean Marie ^b   Perez Diaz, Fernando ^b   Spreux Varoquaux, Odile ^b  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOMIPRAMINE; FLUOXETINE; INOSITOL TRISPHOSPHATE; LYSERGIDE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BINDING SITE; DRUG MECHANISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOPHARMACOTHERAPY; SEROTONIN BLOOD LEVEL; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM; TREATMENT OUTCOME;

EID: 0033387184     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9236(99)90071-1     Document Type: Article

References (38)

1. 1. Stahl SM. Platelets as pharmacologic models for the receptors and biochemistry of monoaminergic neurons. In: Longenecker GL, editor. The platelets: physiology and pharmacology. Orlando (FL): Academic Press; 1985. p. 307-40.
2. 2. Da Prada M, Cesura AM, Launay JM, Richards JG. Platelets as a model of neurons. Experientia 1988;44:115-25.
3. 3. Lesch KP, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993;60:2319-22.
4. 4. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995. p. 933-44.
5. 5. Tuomisto J, Tukiainen E. Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 1976;262:596-8.
6. 6. Meltzer HY, Arora RC. Platelet serotonin studies in affective disorders: evidence for a serotonergic abnormality. In: Sandier M, Coppen A, Harnett S, editors. 5-Hydroxytryptamine in psychiatry: a spectrum of ideas. Oxford: Oxford University Press; 1991. p. 50-89.
7. 7. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994;40:288-95.
8. 2 receptor binding on blood platelets -a peripheral marker for depression? Life Sci 1987;41: 2485-92.
9. 3H-LSD) in the blood platelets of depressed patients. Life Sci 1989;44:725-34.
10. 10. Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 1990;28:215-22.
11. 2 receptors. J Psychiatry Neurosci 1995;20:11-9.
12. 12. Cowen PJ, Charig EM, Fraser S, Elliott JM. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Disord 1987;13: 45-50.
13. 2 receptors, plasma free serotonin and platelet serotonin levels in depressed patients after clomipramine treatment [abstract]. Neuropsychopharmacology 1994;10:4S.
14. 2, receptor indices to major depressive disorder, personality traits and suicidal behavior. Biol Psychiatry 1994;35:295-308.
15. 15. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 1997;41:184-90.
16. 16. Schacter M, Grahame-Smith DG. 5-Hydroxytryptamine and the platelet. Specific binding and uptake. In: De Clerk F, Vanhoutte PM, editors. 5-hydroxytryptamine in peripheral reactions. New York: Raven Press; 1982. p. 83-94.
17. 17. Healy D, Carney PA, Leonard BE. Monoamine related markers of depression: changes following treatment. J Psychiatr Res 1983;17:251-8.
18. 18. Butler J, Leonard BE. The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 1988;3:343-7.
19. 19. Wood K, Swade C, Abou-Saleh M, Coppen A. Peripheral serotonergic receptor sensitivity in depressive illness. J Affect Disord 1984;7:59-65.
20. 2 receptor-mediated function in depressed patients: investigation by measuring 5-HT-induced shape change of blood platelets. Jpn J Psychiatr Neurol 1992;46:169-74.
21. 21. De Chaffoy de Courcelles D, Roevens P, Wynants J, Vanbelle H. Serotonin induced alterations in inositol phospholipid metabolism in human platelets. Biochem Biophys Acta 1987;927:291-302.
22. 22. Berridge MJ. Inositol triphosphate and calcium signaling. Nature 1993;361:315-25.
23. 2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:49-61.
24. 24. Mikuni M, Kagaya A, Takahashi K, Meltzer HY. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology 1992;106:311-4.
25. 2 receptor stimulation in platelets of depressed patients. Biol Psychiatry 1993;34:565-8.
26. 26. Karege F, Bovier P, Rudolph W, Gaillard JM. Platelet phosphoinositide signaling system: an overstimulated pathway in depression. Biol Psychiatry 1996;39:310-2.
27. 3H]inositol 1,4,5-triphosphate binding sites and expressed inositol 1,4,5-triphosphate receptor protein level in platelets of depressed patients. Psychopharmacology 1998;138:47-54.
28. 28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
29. 29. Hamilton M. Diagnosis and rating of anxiety. In: Lader MH, editor. Studies of anxiety. Br J Psychiatry, Spec Pub 1969;3:76-9.
30. 30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
31. 31. Launay JM, Geoffroy C, Mutel V, Buckle M, Cesura A, Alouf JE, Da Prada M. One-step purification of the serotonin transporter located at the human platelet plasma membrane. J Biol Chem 1992;267:11344-51.
32. 32. Spreux-Varoquaux O, Gailledreau J, Vanier B, Bothua D, Plas J, Chevalier JF, et al. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine? Biol Psychiatry 1996;40:465-73.
33. 3H]Paroxetine binding in human platelets in relation to age and sex. Neurobiol Aging 1990:11:615-8.
34. 3H]paroxetine binding to human platelets. J Affect Disord 1998;50:11-5.
35. 35. Leake A, Fairbairn AF, McKeith IG, Ferrier IN. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates. Psychiatry Res 1991;39:155-65.
36. 36. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre-and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995;688:121-33.
37. 37. Anderson GM, Home WC. Activators of protein kinase C decrease serotonin transport in human platelets. Biochim Biophys Acta 1992;1137:331-7.
38. 38. Cowen PJ. The serotonin hypothesis: necessary but not sufficient. In: Feighner JP, Boyer WF, editors. Selective serotonin re-uptake inhibitors: advances in basic research and clinical practice. 2nd ed. John Wiley; 1996. p. 63-86.